Navigating Biomarker & Regulatory Complexity in Clinical Trials

The Parc Científic de Barcelona and Labcorp join forces to host a session on Navigating Biomarker & Regulatory Complexity in Clinical Trials. This event will provide a space to discuss key challenges and strategies in the evolving landscape of clinical research, with a focus on biomarker-driven development and regulatory pathways.

09:00 - 09:45 – Registration

09:45 - 10:00 - Welcome and opening, Grisha Domakowski, Parc Cientific de Barcelona Commercialization & Communication Director and Juan Carlos Saavedra, Business Development Director at Labcorp.

10:00 - 10:45 - Effective Personalized Medicine and Disease Monitoring with Circulating DNA Biomarkers by Alexandre Fort, PhD, Lead Scientist - Genomics at Labcorp.

10:45 - 11: 30 - Current landscape and future perspectives for the role of flow cytometry in drug development, from biomarkers discovery to personalized medicine, by Christele Gonneau, PhD, Global Scientific Director, Flow Cytometry.

11:30 - 12:00 - Coffee break

12:00 – 12:45 - Advancing Biomarker Discovery and Histopathology Through Digital Technologies by Paul Mesange, PhD, Global Director - Histology at Labcorp.

12:45 - 13:30 - Advocating for a Level Playing Field Under IVDR by Sabine Schneider, Vice President Global Government Relations, Corporate Affairs at Labcorp.

13:30 - 14:30 Lunch & networking

About the speakers:

Alexandre Fort, PhD - Lead Scientist, Genomics

Dr. Alexandre Fort joined Labcorp Central Laboratory Services in 2017, bringing more than 15 years of fundamental and clinical genomics research experience. Alexandre has an extensive experience as a research scientist in the field of medical genetics, human genomics and transcriptomics. He is also an author of more than 20 peered-reviewed scientific publications and presentations.

Christèle Gonneau, PhD - Lead Scientist, Flow Cytometry

Dr. Christèle Gonneau graduated with a BS in molecular biology from the Florida Institute of Technology (U.S.) and an MS in human reproductive biology from Imperial College London (U.K.). She then specialized in the field of stem cell biology and completed her PhD at the University of Edinburgh (U.K.) and her four years of postdoctoral training at the Ecole Polytechnique Fédérale de Lausanne (Switzerland).

Paul Mésange, PhD - Global Director - Histology

Dr. Paul Mesange, an engineer with a PhD in pharmacology, has built a career at the intersection of science, clinical trials, and digital innovation. As Global Director of Operations, Histology at Labcorp, he drives efficiency, operational excellence, and digital transformation in clinical trials. Previously, he led global scientific efforts in anatomic pathology, optimizing biomarker research and laboratory processes. His expertise spans oncology, targeted therapies (CGT), and translational research, with significant contributions to Phase II and III clinical trials at Stanford and INSERM. With a strong background in science, automation, and digital transformation, Paul integrates cutting-edge technology to accelerate drug development

Sabine Schneider - Vice President Global Government Relations.

Sabine Schneider has over 30 years of experience in Government Affairs, Marketing, and Corporate Communications in fast moving, competitive business environments. Before she transitioned to her current position in Laboratory Corporation of America Holdings (Labcorp) in 2016 as VP Global Government Relations she was responsible for Corporate Communications for Europe and Asia Pacific.